Target intelligence / Profile preview

Chimerin 1 pseudogene

Molecular classification
Pseudogene, Processed pseudogene, Other
01

Overview

Chimerin 1 pseudogene (ENSG00000250292) is a genomic locus with sequence similarity to the protein-coding CHN1 (chimerin 1) gene but contains mutations that disrupt its coding potential, such as premature stop codons or frameshifts[1][3]. As a pseudogene, it lacks the ability to produce a functional protein product and does not act as a receptor, enzyme, transporter, or other typical drug target. Pseudogenes can be processed (resulting from retrotransposition) or duplicated (from gene duplication), and while most are transcriptionally inactive, some produce RNA that can participate in regulatory networks—e.g., by sponging microRNAs or acting as ceRNAs[4]. However, there is no specific evidence that chimerin 1 pseudogene has such functions or disease associations. Pseudogenes in general are not considered druggable targets, and this locus is not included in therapeutic targeting strategies or biomarker panels. Summary of key points: - Chimerin 1 pseudogene (ENSG00000250292) is a non-coding, defunct genetic locus related to the CHN1 protein-coding gene[3]. - It is not a valid therapeutic target, and thus has no associated drugs, mechanisms, or safety concerns[1][3][4]. - As a pseudogene, its most likely biological impact is as a source of noncoding RNA with potential—though not documented—regulatory function[4].

Other names
Chimerin 1 pseudogeneChimaerin 1 pseudogeneENSG00000250292
02

Biological functions

No canonical protein-coding biological functionMay have regulatory RNA functions such as acting as a miRNA sponge or ceRNA (competing endogenous RNA), typical of some pseudogene transcripts
03

Disease associations

Other

Beyond the preview

Go deeper on Chimerin 1 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chimerin 1 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call